- Home
- CRDF vs ISTR Comparison
CRDF vs ISTR Comparison
Compare CRDF & ISTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRDF
- ISTR
- Stock Information
- Founded
- CRDF 1999
- ISTR 2006
- Country
- CRDF United States
- ISTR United States
- Employees
- CRDF N/A
- ISTR N/A
- Industry
- CRDF Biotechnology: Biological Products (No Diagnostic Substances)
- ISTR Major Banks
- Sector
- CRDF Health Care
- ISTR Finance
- Exchange
- CRDF Nasdaq
- ISTR Nasdaq
- Market Cap
- CRDF 233.5M
- ISTR 189.6M
- IPO Year
- CRDF N/A
- ISTR 2014
- Fundamental
- Price
- CRDF $4.04
- ISTR $21.87
- Analyst Decision
- CRDF Strong Buy
- ISTR Buy
- Analyst Count
- CRDF 6
- ISTR 1
- Target Price
- CRDF $11.92
- ISTR $27.00
- AVG Volume (30 Days)
- CRDF 1.4M
- ISTR 46.0K
- Earning Date
- CRDF 08-07-2025
- ISTR 07-21-2025
- Dividend Yield
- CRDF N/A
- ISTR 1.89%
- EPS Growth
- CRDF N/A
- ISTR 22.25
- EPS
- CRDF N/A
- ISTR 2.19
- Revenue
- CRDF $587,000.00
- ISTR $88,885,000.00
- Revenue This Year
- CRDF N/A
- ISTR $2.04
- Revenue Next Year
- CRDF N/A
- ISTR $9.79
- P/E Ratio
- CRDF N/A
- ISTR $10.12
- Revenue Growth
- CRDF N/A
- ISTR 6.35
- 52 Week Low
- CRDF $2.01
- ISTR $15.39
- 52 Week High
- CRDF $5.64
- ISTR $24.81
- Technical
- Relative Strength Index (RSI)
- CRDF 65.93
- ISTR 70.31
- Support Level
- CRDF $3.07
- ISTR $21.97
- Resistance Level
- CRDF $4.22
- ISTR $22.46
- Average True Range (ATR)
- CRDF 0.22
- ISTR 0.68
- MACD
- CRDF 0.08
- ISTR 0.32
- Stochastic Oscillator
- CRDF 87.35
- ISTR 90.89
About CRDF Cardiff Oncology Inc.
Cardiff Oncology Inc is a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers with the greatest unmet medical need. It is focusing on clinical programs in indications such as RAS-mutated metastatic colorectal cancer ("mCRC"), as well as in investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma ("mPDAC"), small cell lung cancer ("SCLC"), and triple negative breast cancer ("TNBC"). Geographically, the company only operates in the United States.
About ISTR Investar Holding Corporation
Investar Holding Corp is a U.S.-based financial holding company. Through its subsidiaries, it offers a variety of commercial and retail lending products throughout its market areas, including business loans to small to medium-sized businesses, as well as loans to individuals. It has business operations spread across the United States and serves its customers through several service branches. The bank also offers cashiers' checks, direct deposit of payroll and Social Security checks, night depository, bank-by-mail, automated teller machines with deposit automation, and debit cards.